down arrow

Apollo Hospitals

  • Market Cap: Large Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE437A01024
  • NSEID: APOLLOHOSP
  • BSEID: 508869
INR
6,808.90
-31.1 (-0.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.39 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.39 lacs (42.04%) Volume

Shareholding (Dec 2024)

FII

45.27%

Held by 1131 FIIs

DII

20.20%

Held by 90 DIIs

Promoter

29.33%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROCE of 15.06%

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 14.33% and Operating profit at 18.42%

 
3

The company has declared Positive results for the last 5 consecutive quarters

4

Stock is technically in a Mildly Bearish range

5

With ROCE of 16.9, it has a Fair valuation with a 8.6 Enterprise value to Capital Employed

6

High Institutional Holdings at 65.47%

7

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 97,902 Cr (Large Cap)

stock-summary
P/E

75.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.28%

stock-summary
Debt Equity

0.59

stock-summary
Return on Equity

15.77%

stock-summary
Price to Book

13.11

Revenue and Profits (1 Year):
Net Sales:
5,527 Cr
(Quarterly Results - Dec 2024)
Net Profit:
372 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.28%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-2.58%
0.13%
-2.45%
1 Year
4.93%
0.32%
5.25%
2 Years
59.38%
0.74%
60.12%
3 Years
46.05%
1.45%
47.5%
4 Years
117.31%
1.74%
119.05%
5 Years
431.38%
4.49%
435.87%

Latest dividend: 9 per share ex-dividend date: Feb-14-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.33%
EBIT Growth (5y)
18.42%
EBIT to Interest (avg)
3.44
Debt to EBITDA (avg)
2.39
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.51
Tax Ratio
28.69%
Dividend Payout Ratio
25.60%
Pledged Shares
13.47%
Institutional Holding
65.47%
ROCE (avg)
14.96%
ROE (avg)
11.01%
Valuation key factors
Factor
Value
P/E Ratio
75
Industry P/E
55
Price to Book Value
13.11
EV to EBIT
47.68
EV to EBITDA
35.54
EV to Capital Employed
8.59
EV to Sales
4.86
PEG Ratio
1.13
Dividend Yield
0.28%
ROCE (Latest)
16.94%
ROE (Latest)
15.77%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

FIIs

Pledged Promoter Holdings

13.4669

Mutual Funds

Held by 253 Schemes (12.77%)

FIIs

Held by 1131 FIIs (45.27%)

Promoter with highest holding

M/s. Pcr Investments Ltd (18.93%)

Highest Public shareholder

Life Insurance Corporation Of India (3.74%)

Individual Investors Holdings

3.65%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -1.12% vs 9.90% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -1.72% vs 24.12% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,526.90",
          "val2": "5,589.30",
          "chgp": "-1.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "761.50",
          "val2": "815.50",
          "chgp": "-6.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "109.80",
          "val2": "117.50",
          "chgp": "-6.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "372.30",
          "val2": "378.80",
          "chgp": "-1.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.78%",
          "val2": "14.59%",
          "chgp": "-0.81%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 15.22% vs 15.14% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 71.21% vs -23.34% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,674.90",
          "val2": "9,264.70",
          "chgp": "15.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,490.60",
          "val2": "1,136.50",
          "chgp": "31.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "233.90",
          "val2": "217.50",
          "chgp": "7.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1.90",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "684.00",
          "val2": "399.50",
          "chgp": "71.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.96%",
          "val2": "12.27%",
          "chgp": "1.69%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 14.78% vs 14.66% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 63.82% vs -4.42% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16,201.80",
          "val2": "14,115.30",
          "chgp": "14.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,252.10",
          "val2": "1,750.20",
          "chgp": "28.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "343.70",
          "val2": "330.10",
          "chgp": "4.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1.90",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,056.30",
          "val2": "644.80",
          "chgp": "63.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.90%",
          "val2": "12.40%",
          "chgp": "1.50%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 14.73% vs 13.30% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 9.71% vs -22.41% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19,059.20",
          "val2": "16,612.50",
          "chgp": "14.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,390.70",
          "val2": "2,049.60",
          "chgp": "16.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "449.40",
          "val2": "380.80",
          "chgp": "18.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "898.60",
          "val2": "819.10",
          "chgp": "9.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.54%",
          "val2": "12.34%",
          "chgp": "0.20%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
5,526.90
5,589.30
-1.12%
Operating Profit (PBDIT) excl Other Income
761.50
815.50
-6.62%
Interest
109.80
117.50
-6.55%
Exceptional Items
0.00
0.00
Consolidate Net Profit
372.30
378.80
-1.72%
Operating Profit Margin (Excl OI)
13.78%
14.59%
-0.81%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -1.12% vs 9.90% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -1.72% vs 24.12% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
10,674.90
9,264.70
15.22%
Operating Profit (PBDIT) excl Other Income
1,490.60
1,136.50
31.16%
Interest
233.90
217.50
7.54%
Exceptional Items
0.00
1.90
-100.00%
Consolidate Net Profit
684.00
399.50
71.21%
Operating Profit Margin (Excl OI)
13.96%
12.27%
1.69%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 15.22% vs 15.14% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 71.21% vs -23.34% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
16,201.80
14,115.30
14.78%
Operating Profit (PBDIT) excl Other Income
2,252.10
1,750.20
28.68%
Interest
343.70
330.10
4.12%
Exceptional Items
0.00
1.90
-100.00%
Consolidate Net Profit
1,056.30
644.80
63.82%
Operating Profit Margin (Excl OI)
13.90%
12.40%
1.50%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 14.78% vs 14.66% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 63.82% vs -4.42% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
19,059.20
16,612.50
14.73%
Operating Profit (PBDIT) excl Other Income
2,390.70
2,049.60
16.64%
Interest
449.40
380.80
18.01%
Exceptional Items
1.90
0.00
Consolidate Net Profit
898.60
819.10
9.71%
Operating Profit Margin (Excl OI)
12.54%
12.34%
0.20%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 14.73% vs 13.30% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 9.71% vs -22.41% in Mar 2023

stock-summaryCompany CV
About Apollo Hospitals Enterprise Ltd. stock-summary
stock-summary
Apollo Hospitals Enterprise Ltd.
Large Cap
Hospital & Healthcare Services
Apollo Hospitals Enterprise Limited (AHEL) is a leading private sector healthcare provider in Asia. It has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics. AHEL's Hospitals are situated in Chennai, Hyderabad, Delhi, Ahmedabad, Pune, Chenganur, Coimbatore, Jaipur, Madurai, Anantpur, Nellore, Kurnool, Bhopal, Ranchi, Bilaspur and Bacheli.
Company Coordinates stock-summary
Company Details
No 19 Bishop Garden, Raja Annamalaipuram Chennai Tamil Nadu : 600028
stock-summary
Tel: 91-44-28290956/28293896
stock-summary
apolloshares@vsnl.net
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai